{
    "pmcid": "10702856",
    "qa_pairs": {
        "What is the main advantage of the Gigabody design in terms of binding affinity?": [
            "Enhancing binding affinity through avidity effects",
            "Increasing the number of epitopes displayed",
            "Reducing the size of the nanoparticle for better penetration",
            "Improving the thermostability of the nanobody"
        ],
        "What is the primary function of the ADDoCoV vaccine as described in the study?": [
            "To display 60 copies of an epitope derived from the SARS-CoV-2 RBM",
            "To deliver mRNA encoding the SARS-CoV-2 spike protein",
            "To provide a live attenuated virus for immune system training",
            "To use a viral vector to express the SARS-CoV-2 nucleocapsid protein"
        ],
        "What technique was used to generate neutralizing nanobodies from a na\u00efve camelid single-domain antibody library?": [
            "Ribosome Display",
            "Phage Display",
            "Yeast Surface Display",
            "Bacterial Display"
        ],
        "What was a key feature of the ADDoCoV and Gigabody that aids in their distribution without refrigeration?": [
            "Thermostable ADDomer scaffold",
            "Lyophilized formulation",
            "Encapsulation in lipid nanoparticles",
            "Use of a viral vector platform"
        ],
        "Which SARS-CoV-2 variants did the nanobody ADAH11 show cross-reactivity with?": [
            "Delta and Omicron",
            "Alpha and Beta",
            "Gamma and Lambda",
            "Mu and Epsilon"
        ]
    }
}